During the past decade, Eugastro Gmbh conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 22 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 22 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eugastro Gmbh" #1 sponsor was "Celgene" with 7 trials, followed by "Gilead Sciences" with 7 trials sponsored, "Takeda" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Arrowhead Pharmaceuticals" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eugastro Gmbh" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "ClinIntel" with 1 trials as a collaborator, "Clinical Reference Laboratory" with 1 trials as a collaborator and "Cristcot HCA LLC" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Eugastro Gmbh" are "Crohn's Disease" (9 trials), "Ulcerative Colitis" (6 trials), "Colitis, Ulcerative" (4 trials), "Crohn Disease" (3 trials) and "Hepatitis B" (3 trials). Many other conditions were trialed in "Eugastro Gmbh" in a lesser frequency.

Most popular intervention types in "Eugastro Gmbh" are "Drug" (38 trials), "Biological" (5 trials), "Other" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Filgotinib" (4 trials), "GED-0301" (3 trials), "Guselkumab" (3 trials) and "antihistamine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Eugastro Gmbh" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Eugastro Gmbh". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Eugastro Gmbh, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Eugastro Gmbh, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".